Novo Nordisk gears up for FDA filing with late-phase insulin plus semaglutide data

Novo Nordisk, with data on-hand from a late-stage trial of IcoSema, is preparing for an FDA filing in type 2 diabetes slated for the second …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Genome-wide association study identifies genetic risk factors for dementia

In landmark research, scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have reported the largest-ever genome-wide association

September 18, 2024

Key Improvement in Targeting Could Bring in Next Generation Cell and Gene Therapies

Credit: Design Cells/Getty Images Research led by the University of Pennsylvania has discovered that a viral method of entering cells can be harnessed to get

May 1, 2023

Cannabis Investors Shouldn’t Fear This Situation

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter

July 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.